Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
7 "Brain Neoplasms"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Review
Molecular Testing of Brain Tumor
Sung-Hye Park, Jaekyung Won, Seong-Ik Kim, Yujin Lee, Chul-Kee Park, Seung-Ki Kim, Seung-Hong Choi
J Pathol Transl Med. 2017;51(3):205-223.   Published online May 12, 2017
DOI: https://doi.org/10.4132/jptm.2017.03.08
  • 29,666 View
  • 1,155 Download
  • 39 Web of Science
  • 42 Crossref
AbstractAbstract PDF
The World Health Organization (WHO) classification of central nervous system (CNS) tumors was revised in 2016 with a basis on the integrated diagnosis of molecular genetics. We herein provide the guidelines for using molecular genetic tests in routine pathological practice for an accurate diagnosis and appropriate management. While astrocytomas and IDH-mutant (secondary) glioblastomas are characterized by the mutational status of IDH, TP53, and ATRX, oligodendrogliomas have a 1p/19q codeletion and mutations in IDH, CIC, FUBP1, and the promoter region of telomerase reverse transcriptase (TERTp). IDH-wildtype (primary) glioblastomas typically lack mutations in IDH, but are characterized by copy number variations of EGFR, PTEN, CDKN2A/B, PDGFRA, and NF1 as well as mutations of TERTp. High-grade pediatric gliomas differ from those of adult gliomas, consisting of mutations in H3F3A, ATRX, and DAXX, but not in IDH genes. In contrast, well-circumscribed low-grade neuroepithelial tumors in children, such as pilocytic astrocytoma, pleomorphic xanthoastrocytoma, and ganglioglioma, often have mutations or activating rearrangements in the BRAF, FGFR1, and MYB genes. Other CNS tumors, such as ependymomas, neuronal and glioneuronal tumors, embryonal tumors, meningothelial, and other mesenchymal tumors have important genetic alterations, many of which are diagnostic, prognostic, and predictive markers and therapeutic targets. Therefore, the neuropathological evaluation of brain tumors is increasingly dependent on molecular genetic tests for proper classification, prediction of biological behavior and patient management. Identifying these gene abnormalities requires cost-effective and high-throughput testing, such as next-generation sequencing. Overall, this paper reviews the global guidelines and diagnostic algorithms for molecular genetic testing of brain tumors.

Citations

Citations to this article as recorded by  
  • PTEN regulates expression of its pseudogene in glioblastoma cells in DNA methylation-dependent manner
    Tatyana F. Kovalenko, Bhupender Yadav, Ksenia S. Anufrieva, Tatyana D. Larionova, Tatiana E. Aksinina, Yaroslav A. Latyshev, Soniya Bastola, Michail I. Shakhparonov, Amit Kumar Pandey, Marat S. Pavlyukov
    Biochimie.2024; 219: 74.     CrossRef
  • CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization
    Manali Ranade, Sridhar Epari, Omshree Shetty, Sandeep Dhanavade, Sheetal Chavan, Ayushi Sahay, Arpita Sahu, Prakash Shetty, Aliasgar Moiyadi, Vikash Singh, Archya Dasgupta, Abhishek Chatterjee, Sadhana Kannan, Tejpal Gupta
    Journal of Neuro-Oncology.2024; 167(1): 189.     CrossRef
  • Central neurocytoma exhibits radial glial cell signatures with FGFR3 hypomethylation and overexpression
    Yeajina Lee, Tamrin Chowdhury, Sojin Kim, Hyeon Jong Yu, Kyung-Min Kim, Ho Kang, Min-Sung Kim, Jin Wook Kim, Yong-Hwy Kim, So Young Ji, Kihwan Hwang, Jung Ho Han, Jinha Hwang, Seong-Keun Yoo, Kyu Sang Lee, Gheeyoung Choe, Jae-Kyung Won, Sung-Hye Park, Yon
    Experimental & Molecular Medicine.2024; 56(4): 975.     CrossRef
  • Liquid biopsy in brain tumors: Potential for impactful clinical applications
    Tania Eid, Lina Ghandour, Joseph Abi Ghanem, Hazem Assi, Rami Mahfouz
    Human Gene.2024; 42: 201333.     CrossRef
  • Diagnostic challenges in complicated case of glioblastoma
    Tatiana Aghova, Halka Lhotska, Libuse Lizcova, Karla Svobodova, Lucie Hodanova, Karolina Janeckova, Kim Vucinic, Martin Gregor, Dora Konecna, Filip Kramar, Jiri Soukup, David Netuka, Zuzana Zemanova
    Pathology and Oncology Research.2024;[Epub]     CrossRef
  • Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario
    Marina Ferreira Candido, Mariana Medeiros, Luciana Chain Veronez, David Bastos, Karla Laissa Oliveira, Julia Alejandra Pezuk, Elvis Terci Valera, María Sol Brassesco
    Pharmaceutics.2023; 15(2): 664.     CrossRef
  • BrainBase: a curated knowledgebase for brain diseases
    Lin Liu, Yang Zhang, Guangyi Niu, Qianpeng Li, Zhao Li, Tongtong Zhu, Changrui Feng, Xiaonan Liu, Yuansheng Zhang, Tianyi Xu, Ruru Chen, Xufei Teng, Rongqin Zhang, Dong Zou, Lina Ma, Zhang Zhang
    Nucleic Acids Research.2022; 50(D1): D1131.     CrossRef
  • A heat shock protein 90 inhibitor reduces oncoprotein expression and induces cell death in heterogeneous glioblastoma cells with EGFR, PDGFRA, CDK4, and NF1 aberrations
    Kuan-Ta Ho, Pei-Fan Chen, Jian-Ying Chuang, Po-Wu Gean, Yuan-Shuo Hsueh
    Life Sciences.2022; 288: 120176.     CrossRef
  • Bicentric validation of the navigated transcranial magnetic stimulation motor risk stratification model
    Tizian Rosenstock, Levin Häni, Ulrike Grittner, Nicolas Schlinkmann, Meltem Ivren, Heike Schneider, Andreas Raabe, Peter Vajkoczy, Kathleen Seidel, Thomas Picht
    Journal of Neurosurgery.2022; 136(4): 1194.     CrossRef
  • Foramen magnum meningioma presented as cervical myelopathy in a pregnant COVID-19 patient: A case report
    Olivia Josephine Wijaya, Djohan Ardiansyah
    Annals of Medicine and Surgery.2022; 77: 103647.     CrossRef
  • The telomere maintenance mechanism spectrum and its dynamics in gliomas
    Sojin Kim, Tamrin Chowdhury, Hyeon Jong Yu, Jee Ye Kahng, Chae Eun Lee, Seung Ah. Choi, Kyung-Min Kim, Ho Kang, Joo Ho Lee, Soon-Tae Lee, Jae-Kyung Won, Kyung Hyun Kim, Min-Sung Kim, Ji Yeoun Lee, Jin Wook Kim, Yong-Hwy Kim, Tae Min Kim, Seung Hong Choi,
    Genome Medicine.2022;[Epub]     CrossRef
  • A review of predictive, prognostic and diagnostic biomarkers for brain tumours: towards personalised and targeted cancer therapy
    Ernest Osei, Pascale Walters, Olivia Masella, Quinton Tennant, Amber Fishwick, Eugenia Dadzie, Anmol Bhangu, Johnson Darko
    Journal of Radiotherapy in Practice.2021; 20(1): 83.     CrossRef
  • Use of a novel navigable tubular retractor system in 1826 minimally invasive parafascicular surgery (MIPS) cases involving deep-seated brain tumors, hemorrhages and malformations
    Martina M. Cartwright, Penny Sekerak, Joseph Mark, Julian Bailes
    Interdisciplinary Neurosurgery.2021; 23: 100919.     CrossRef
  • Disentangling the therapeutic tactics in GBM: From bench to bedside and beyond
    S. Daisy Precilla, Shreyas S. Kuduvalli, Anitha Thirugnanasambandhar Sivasubramanian
    Cell Biology International.2021; 45(1): 18.     CrossRef
  • Sequencing of a central nervous system tumor demonstrates cancer transmission in an organ transplant
    Marie-Claude Gingras, Aniko Sabo, Maria Cardenas, Abbas Rana, Sadhna Dhingra, Qingchang Meng, Jianhong Hu, Donna M Muzny, Harshavardhan Doddapaneni, Lesette Perez, Viktoriya Korchina, Caitlin Nessner, Xiuping Liu, Hsu Chao, John Goss, Richard A Gibbs
    Life Science Alliance.2021; 4(9): e202000941.     CrossRef
  • Radiogenomics of Gliomas
    Chaitra Badve, Sangam Kanekar
    Radiologic Clinics of North America.2021; 59(3): 441.     CrossRef
  • Chemical analysis of the human brain by imaging mass spectrometry
    Akhila Ajith, Yeswanth Sthanikam, Shibdas Banerjee
    The Analyst.2021; 146(18): 5451.     CrossRef
  • Correlation between Stage and Histopathological Features and Clinical Outcomes in Patients with Glioma Tumors
    Andre Lona, Alfansuri Kadri, Irina Kemala Nasution
    Open Access Macedonian Journal of Medical Sciences.2021; 9(T3): 262.     CrossRef
  • Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment
    Yusuke Funakoshi, Nobuhiro Hata, Daisuke Kuga, Ryusuke Hatae, Yuhei Sangatsuda, Yutaka Fujioka, Kosuke Takigawa, Masahiro Mizoguchi
    Cancers.2021; 13(4): 758.     CrossRef
  • Discovery of clinically relevant fusions in pediatric cancer
    Stephanie LaHaye, James R. Fitch, Kyle J. Voytovich, Adam C. Herman, Benjamin J. Kelly, Grant E. Lammi, Jeremy A. Arbesfeld, Saranga Wijeratne, Samuel J. Franklin, Kathleen M. Schieffer, Natalie Bir, Sean D. McGrath, Anthony R. Miller, Amy Wetzel, Katheri
    BMC Genomics.2021;[Epub]     CrossRef
  • Clinicopathological correlation of glioma patients with respect to immunohistochemistry markers: A prospective study of 115 patients in a Tertiary Care Hospital in North India
    Gitanshu Dahuja, Ashok Gupta, Arpita Jindal, Gaurav Jain, Santosh Sharma, Arvind Kumar
    Asian Journal of Neurosurgery.2021; 16(04): 732.     CrossRef
  • Role of Extracellular Vesicles in Glioma Progression: Deciphering Cellular Biological Processes to Clinical Applications
    Rashmi Rana, Shikha Joon, Kirti Chauhan, Vaishnavi Rathi, Nirmal Kumar Ganguly, Chandni Kumari, Dharmendra Kumar Yadav
    Current Topics in Medicinal Chemistry.2021; 21(8): 696.     CrossRef
  • A comprehensive overview on the molecular biology of human glioma: what the clinician needs to know
    P. D. Delgado-López, P. Saiz-López, R. Gargini, E. Sola-Vendrell, S. Tejada
    Clinical and Translational Oncology.2020; 22(11): 1909.     CrossRef
  • Use of Fluorescence In Situ Hybridization (FISH) in Diagnosis and Tailored Therapies in Solid Tumors
    Natalia Magdalena Chrzanowska, Janusz Kowalewski, Marzena Anna Lewandowska
    Molecules.2020; 25(8): 1864.     CrossRef
  • From Banding to BAM Files
    Adrian M. Dubuc
    Surgical Pathology Clinics.2020; 13(2): 343.     CrossRef
  • Mutation profiling of anaplastic ependymoma grade III by Ion Proton next generation DNA sequencing
    Ejaz Butt, Sabra Alyami, Tahani Nageeti, Muhammad Saeed, Khalid AlQuthami, Abdellatif Bouazzaoui, Mohammad Athar, Zainularifeen Abduljaleel, Faisal Al-Allaf, Mohiuddin Taher
    F1000Research.2020; 8: 613.     CrossRef
  • Assessment of the non-linear optical behavior of cells for discrimination between normal and malignant glial cells
    Soraya Emamgholizadeh Minaei, Alireza Ghader, Ali Abbasian Ardakani, Samideh Khoei, Mohammad Hosein Majles Ara
    Laser Physics.2020; 30(12): 125601.     CrossRef
  • Mutation profiling of anaplastic ependymoma grade III by Ion Proton next generation DNA sequencing
    Muhammad Butt, Sabra Alyami, Tahani Nageeti, Muhammad Saeed, Khalid AlQuthami, Abdellatif Bouazzaoui, Mohammad Athar, Zainularifeen Abduljaleel, Faisal Al-Allaf, Mohiuddin Taher
    F1000Research.2019; 8: 613.     CrossRef
  • A Multiplex Quantitative Reverse Transcription Polymerase Chain Reaction Assay for the Detection of KIAA1549–BRAF Fusion Transcripts in Formalin-Fixed Paraffin-Embedded Pilocytic Astrocytomas
    David Bret, Valentin Chappuis, Delphine Poncet, François Ducray, Karen Silva, Fabrice Mion, Alexandre Vasiljevic, Carole Ferraro-Peyret, Carmine Mottolese, Pierre Leblond, Mathieu Gabut, Didier Frappaz, Nathalie Streichenberger, David Meyronet, Pierre-Pau
    Molecular Diagnosis & Therapy.2019; 23(4): 537.     CrossRef
  • A PTPmu Biomarker is Associated with Increased Survival in Gliomas
    Mette L. Johansen, Jason Vincent, Haley Gittleman, Sonya E. L. Craig, Marta Couce, Andrew E. Sloan, Jill S. Barnholtz-Sloan, Susann M. Brady-Kalnay
    International Journal of Molecular Sciences.2019; 20(10): 2372.     CrossRef
  • ATRX Mutations in Pineal Parenchymal Tumors of Intermediate Differentiation
    Haydee Martínez, Michelle Nagurney, Zi-Xuan Wang, Charles G Eberhart, Christopher M Heaphy, Mark T Curtis, Fausto J Rodriguez
    Journal of Neuropathology & Experimental Neurology.2019; 78(8): 703.     CrossRef
  • The role of fibroblast growth factors and their receptors in gliomas: the mutations involved
    Vasiliki Georgiou, Vasiliki Gkretsi
    Reviews in the Neurosciences.2019; 30(5): 543.     CrossRef
  • The Role of Next Generation Sequencing in Diagnosis of Brain Tumors: A Review Study
    Sadegh Shirian, Yahya Daneshbod, Saranaz Jangjoo, Amir Ghaemi, Arash Goodarzi, Maryam Ghavideldarestani, Ahmad Emadi, Arman Ai, Akbar Ahmadi, Jafar Ai
    Archives of Neuroscience.2019;[Epub]     CrossRef
  • Applied Precision Cancer Medicine in Neuro-Oncology
    H. Taghizadeh, L. Müllauer, J. Furtner, J. A. Hainfellner, C. Marosi, M. Preusser, G. W. Prager
    Scientific Reports.2019;[Epub]     CrossRef
  • Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomas
    Joshua Loewenstern, John Rutland, Corey Gill, Hanane Arib, Margaret Pain, Melissa Umphlett, Yayoi Kinoshita, Russell McBride, Michael Donovan, Robert Sebra, Joshua Bederson, Mary Fowkes, Raj Shrivastava
    Oncotarget.2019; 10(37): 3506.     CrossRef
  • Next generation DNA sequencing of atypical choroid plexus papilloma of brain: Identification of novel mutations in a female patient by Ion Proton
    Mohiuddin Taher, Amal Hassan, Muhammad Saeed, Raid Jastania, Tahani Nageeti, Hisham Alkhalidi, Ghida Dairi, Zainularifeen Abduljaleel, Mohammad Athar, Abdellatif Bouazzaoui, Wafa El‑Bjeirami, Faisal Al‑Allaf
    Oncology Letters.2019;[Epub]     CrossRef
  • Pure mechanistic analysis of additive neuroprotective effects between baicalin and jasminoidin in ischemic stroke mice
    Peng-qian Wang, Qiong Liu, Wen-juan Xu, Ya-nan Yu, Ying-ying Zhang, Bing Li, Jun Liu, Zhong Wang
    Acta Pharmacologica Sinica.2018; 39(6): 961.     CrossRef
  • The Smad4/PTEN Expression Pattern Predicts Clinical Outcomes in Colorectal Adenocarcinoma
    Yumin Chung, Young Chan Wi, Yeseul Kim, Seong Sik Bang, Jung-Ho Yang, Kiseok Jang, Kyueng-Whan Min, Seung Sam Paik
    Journal of Pathology and Translational Medicine.2018; 52(1): 37.     CrossRef
  • Primary brain tumours in adults
    Sarah Lapointe, Arie Perry, Nicholas A Butowski
    The Lancet.2018; 392(10145): 432.     CrossRef
  • Epidemiology and Overview of Gliomas
    Mary Elizabeth Davis
    Seminars in Oncology Nursing.2018; 34(5): 420.     CrossRef
  • Toward Precision Medicine: Promising Areas of Research in Glioma
    Mary Elizabeth Davis, Dana Bossert, Malbora Manne
    Seminars in Oncology Nursing.2018; 34(5): 569.     CrossRef
  • Molecular Basis of Pediatric Brain Tumors
    Alexia Klonou, Christina Piperi, Antonios N. Gargalionis, Athanasios G. Papavassiliou
    NeuroMolecular Medicine.2017; 19(2-3): 256.     CrossRef
Original Article
Immunohistochemical Expression of Synaptophysin in Brain Tumors.
Byung Ha Choi, Shin Kwang Khang
Korean J Pathol. 2001;35(5):433-439.
  • 3,393 View
  • 110 Download
AbstractAbstract PDF
BACKGROUND
Perikaryal or perikaryal surface immunostaining for synaptophysin has been posited to distinguish the neoplastic neuronal elements of gangliogliomas from entrapped non-neoplastic neurons in other gliomas of various types. However, recent studies revealed that perikaryal surface immunoreactivity can be seen in the neurons of normal human spinal cords and brains, as well as in the brain tissues around certain non-neuronal lesions. To access the validity of this criterion in the diagnosis of ganglion cell neoplasms, we evaluated patterns of immunostaining of synaptophysin in neuronal, glial and some non-neuroepithelial tumors.
METHODS
We selected 104 cases of gangliogliomas, gangliocytomas, central neurocytomas, dysembryoplastic neuroepithelial tumors, astrocytomas, oligodendrogliomas, glioblastomas, a pleomorphic xanthoastrocytoma, meningiomas, arterio-venous malformations, craniopharyngiomas, a foreign body granuloma, temporal lobe epilepsies, and autopsied brains. A representative block including the gray matter was identified for each case, and synaptophysin immunostaining was performed.
RESULTS
Perikaryal and perikaryal surface immunoreactivity for synaptophysin was observed in the neurons of various types of lesions. Percentage of perikaryal and perikaryal surface immunoreactivity of the gangliogliomas, glial tumors, and non-neuroepithelial lesions were 100%/93%, 80%/58% and 57%/26%, respectively.
CONCLUSIONS
Although synaptophysin positive neurons are found in the ganglioglioma, these patterns are clearly not pathognomonic for glioneuronal tumors.
Case Reports
Chordoid Glioma: A Case Report.
Jang Hee Kim, Jae Ho Han, Chull Shim
Korean J Pathol. 2002;36(1):66-69.
  • 1,499 View
  • 12 Download
AbstractAbstract PDF
The chordoid glioma is a recently recognized rare neoplasm of the third ventricle and hypothalamus and, as the name implies, has a chordoid appearance. Using histological, immunohistochemical and ultrastructural studies, we report a case of a 32-year-old man with a chordoid glioma in the third ventricle. Magnetic resonance T1-weighted images of the brain with homogenous contrast enhancement revealed a well circumscribed, isointense mass occupying the third ventricle. Histologically, the tumor showed cords and clusters of epithelioid cells within a mucinous background along with lymphoplasmacytic infiltrate, and appeared to be reminiscent of a chordoma or chordoid meningioma. Immunohistochemically, the tumor cells were immunoreactive for glial fibrillary acidic protein, vimentin and CD34 but negative for epithelial membrane antigen. Ultrastructural study revealed round to spindle shaped cells with abundant cytoplasmic intermediate filaments and cytoplasmic zonation.
Chordoid Glioma: A Report of Two Cases.
Eun Jung Park, Hyun Sik O, Min Cheol Lee
Korean J Pathol. 2002;36(5):357-361.
  • 1,599 View
  • 14 Download
AbstractAbstract PDF
Chordoid glioma mainly occurs in the third ventricle, pineal gland, hypothalamus, and suprasella. We report two cases of chordoid gliomas of the third ventricles in adult males. Histologically, the tumors consisted of cords and clusters of oval to polygonal epitheliod cells with abundant cytoplasm. The backgrounds of the tumor show mucinous and lymphoplasmacytic infiltrates. Immunohistochemically, the tumor cells were positive for glial fibrillary acidic protein and negative for epithelial membrane antigen, cytokeratin and neurofilament protein. Histopathologic diagnosis of chordoid glioma should be made judiciously by differentiating them from other chordoid or epithelial tumors of the central nervous system.
Original Article
Alterations of 9p21-22 Region Encoding Genes in Primary Glioblastomas.
Hong Jik Doh, Seong Il Suh, Dong Won Kim, Il Man Kim, Man Bin Yim, Eun Ik Son, Kun Young Kwon, Sang Sook Lee, Sang Pyo Kim
Korean J Pathol. 2002;36(6):394-399.
  • 1,543 View
  • 16 Download
AbstractAbstract PDF
BACKGROUND
Glioblastomas are one of the most common and aggressive malignant glial tumors occuring in the central nervous system. This study analyzed the status of p15INK4b, p14ARF, p16INK4a, MTAP, IFNA, and IFNB genes in 36 primary glioblastomas to investigate whether the inactivation of these genes participate in primary glioblastoma tumorigenesis.
METHODS
We used polymerase chain reaction, polymerase chain reaction/single strand conformational polymorphism (PCR/SSCP) analysis, and methylation-specific PCR.
RESULTS
Homozygous deletions at the p16INK4a gene were detected in 11 cases (30.5%) of 36 primary glioblastomas, and the promoter hypermethylation was found in 3 cases (8.3%) of 36 primary glioblastomas. In mutational analysis for the p16INK4a gene by PCR/SSCP, there was no abnormal mobility-shifted band in 36 cases of primary glioblastomas. The overall frequency of p16INK4a alterations including homozygous deletion and promoter hypermethylation in 36 primary glioblastomas was 38.8% (14 of 36). Deletions of p15INK4b were noted in 4 cases (11.1%), whereas deletions of the p14ARF and MTAP genes were detected in 1 case of 36 cases of primary glioblastomas. But deletions of the INFA and B genes were not found.
CONCLUSIONS
These results suggest that alterations of the p16INK4a gene can be important mechanisms of the tumorigenesis of primary glioblastomas, and the p16INK4a gene is inactivated by mechanisms including homozygous deletion and promoter hypermethylation.
Case Reports
Congenital Desmoplastic Cerebral Glioblastoma: A Case Report.
Hong Il Ha, Seung Mo Hong, Seung Koo Lee, Shin Kwang Khang
Korean J Pathol. 2002;36(6):440-444.
  • 1,658 View
  • 26 Download
AbstractAbstract PDF
Desmoplastic cerebral glioblastoma has been described recently and is a very rare histologic variant of glioblastoma. We report a case of congenital cerebral glioblastoma associated with intense desmoplastic stromal reaction. A male infant was born at 36 gestational weeks by Cesarian section. He had a brain tumor, which was detected by fetal ultrasonography. The tumor was partially resected 2 months after the day of the boy's birth and totally resected when he was one year old. The microscopic features of the tumor were those of glioblastoma, including high cellularity, frequent mitotic figures, vascular endothelial proliferation, and geographic palisading necrosis. The tumor showed an area of intense desmoplasia where tumor cells were surrounded by dense reticulin fibers. The desmoplastic cerebral tumors in children may be a distinct group of brain tumor, and it is important to understand the entity of these tumors which generally seem to be associated with more favorable prognosis compared to other high grade brain tumors.
Suprasellar Endodermal Sinus Tumor Presenting with Tonic-Clonic Seizure: An Autopsy Case Report.
Min Jin Lee, Hea Soo Koo, Woon Sup Han, Sun Hee Sung, Yong Jae Kim, Hye Young Choi
Korean J Pathol. 2002;36(6):433-439.
  • 1,567 View
  • 13 Download
AbstractAbstract PDF
We report the clinical course and autopsy findings of a 19-year-old girl with endodermal sinus tumor involving the thalamus, hypothalamus, and basal ganglia. The patient initially had tonic-clonic seizures with abnormal signal involving the right hippocampus, amygdala, basal ganglia, putamen, and dentate gyrus. The signal intensity of the posterior pituitary on T1-weighted images was decreased at the time of admission, which was not associated with clinical symptoms of diabetes insipidus (DI). A huge tumor mass as well as central DI developed within 10 months. The postmortem examination showed gliosis with calcification involving the right basal ganglia, internal capsule, and white matter, in addition to a tumor mass involving the thalamus, hypothalamus, and basal ganglia. Dissemination of tumor cells in the leptomeninges and the gliotic area and hydrocephalus were also noted.

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP